Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 19 studies | 24% ± 7% | |
| myofibroblast cell | 4 studies | 32% ± 12% | |
| cardiac muscle cell | 4 studies | 16% ± 0% | |
| astrocyte | 4 studies | 24% ± 3% | |
| muscle cell | 3 studies | 34% ± 13% | |
| GABAergic neuron | 3 studies | 31% ± 8% | |
| glutamatergic neuron | 3 studies | 38% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 27% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 93% | 17484.02 | 228 / 245 | 81% | 4.94 | 406 / 502 |
| uterus | 98% | 31086.38 | 166 / 170 | 62% | 7.73 | 286 / 459 |
| brain | 50% | 4019.65 | 1320 / 2642 | 100% | 12.08 | 702 / 705 |
| esophagus | 70% | 24894.02 | 1015 / 1445 | 61% | 4.52 | 111 / 183 |
| ovary | 44% | 5127.22 | 79 / 180 | 74% | 5.35 | 318 / 430 |
| bladder | 86% | 26774.14 | 18 / 21 | 31% | 1.88 | 154 / 504 |
| muscle | 100% | 41185.68 | 803 / 803 | 0% | 0 | 0 / 0 |
| breast | 42% | 3607.34 | 195 / 459 | 57% | 3.08 | 642 / 1118 |
| blood vessel | 100% | 63326.05 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 75% | 30517.96 | 725 / 966 | 19% | 1.09 | 99 / 527 |
| heart | 87% | 11954.29 | 748 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 4% | 302.18 | 11 / 258 | 72% | 21.45 | 165 / 230 |
| stomach | 43% | 13473.91 | 154 / 359 | 29% | 2.59 | 82 / 286 |
| lung | 15% | 1170.86 | 84 / 578 | 40% | 2.60 | 463 / 1155 |
| pancreas | 0% | 0 | 0 / 328 | 52% | 2.84 | 92 / 178 |
| adipose | 36% | 3691.68 | 438 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 1.29 | 13 / 45 |
| thymus | 7% | 661.76 | 47 / 653 | 17% | 0.57 | 100 / 605 |
| skin | 7% | 485.12 | 118 / 1809 | 9% | 0.47 | 44 / 472 |
| kidney | 3% | 254.08 | 3 / 89 | 11% | 0.50 | 103 / 901 |
| liver | 0% | 0 | 0 / 226 | 11% | 1.22 | 46 / 406 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.05 | 2 / 80 |
| spleen | 0% | 21.92 | 1 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 5.42 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0007517 | Biological process | muscle organ development |
| GO_0042692 | Biological process | muscle cell differentiation |
| GO_0005634 | Cellular component | nucleus |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0004672 | Molecular function | protein kinase activity |
| Gene name | SPEG |
| Protein name | Aortic preferentially expressed gene 1, isoform CRA_i (Striated muscle enriched protein kinase) Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1) Striated muscle enriched protein kinase |
| Synonyms | APEG1 hCG_2012857 KIAA1297 |
| Description | FUNCTION: Isoform 3 may have a role in regulating the growth and differentiation of arterial smooth muscle cells. |
| Accessions | ENST00000396689.2 [Q15772-4] H0Y3W0 ENST00000396686.5 [Q15772-4] ENST00000431523.5 H7C3Y5 ENST00000312358.12 [Q15772-5] ENST00000420132.5 G5E9J7 C9JWU5 Q15772 F8WCA7 ENST00000396698.5 ENST00000403148.6 ENST00000409595.2 B9ZVR7 ENST00000452101.1 ENST00000396688.5 [Q15772-4] ENST00000435853.5 ENST00000451076.1 C9J8D8 |
